Exagen Inc (XGN) support and resistance · rev $37.2M
Exagen Inc (XGN) is a diagnostics & research company listed on US.
This page maps Exagen Inc (XGN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported XGN revenue for 2026-06-30 was $37.2M. Net income was -$7.2M. XGN currently screens at market cap $154.1M.
XGN currently screens at market cap $154.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new XGN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the XGN quote page for the session range and the stock page for the full model.
Not investment advice.